4/A
Changes in Ownership
BRAINSTORM CELL THERAPEUTICS INC. Filed Acc 0001104659-24-084334
President & CEO bought 245,072 shares at an average $0.54 ($131,411)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lebovits Chaim President & CEO | 2024-04-17 | Purchase | +130,000 | $0.55 | $70,941 | 728,493 | D: show line 1 in the form |
| Lebovits Chaim President & CEO | 2024-04-18 | Purchase | +115,072 | $0.53 | $60,470 | 843,565 | D: show line 2 in the form |
| Open-market purchases · 245,072 sh · avg $0.54 · $131,411 | |||||||
Loading xslF345X05/tm2420560-1_4aseq1.xml…